Advances in management of the female athlete triad and eating disorders

Clinics in Sports Medicine

Volumn 30, Issue 3, 2011, Pages 551-573

  Zach, Karie N ^a   Smith Machin, Ariane L ^a   Hoch, Anne Z ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Disordered eating; Endothelial dysfunction; Female athlete triad; Folic acid

Indexed keywords

ANTICONVULSIVE AGENT; ANTIOBESITY AGENT; ATOMOXETINE; ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; FOLIC ACID; GESTAGEN; OLANZAPINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; ZYREXA;

AEROBIC EXERCISE; AGE DISTRIBUTION; AMENORRHEA; BONE DENSITY; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR RISK; CLINICAL FEATURE; COGNITIVE THERAPY; COMPETITION; DISEASE ASSOCIATION; DRUG MEGADOSE; EATING DISORDER; ENDOTHELIAL DYSFUNCTION; ENERGY YIELD; ETHNICITY; FEMALE; FEMALE ATHLETE TRIAD; HEALTH PROGRAM; HIGH RISK POPULATION; HISTORY; HORMONE SUBSTITUTION; HUMAN; LOW DRUG DOSE; MENSTRUATION; MENSTRUATION DISORDER; OSTEOPENIA; OSTEOPOROSIS; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN DISEASE; SLEEP DISORDER; STANDARD; STOMACH DISCOMFORT; TREATMENT DURATION;

ADOLESCENT; AMENORRHEA; ATHLETES; BONE DENSITY; COGNITIVE THERAPY; DRUG THERAPY; EATING DISORDERS; ENERGY INTAKE; FEMALE; FOLIC ACID; HUMANS; MENSTRUATION; UNITED STATES;

EID: 79958139930     PISSN: 02785919     EISSN: 1556228X     Source Type: Journal    
DOI: 10.1016/j.csm.2011.03.005     Document Type: Review

References (146)

1. NFSHSA 2009-10 high school athletics participation survey: based on competition at the high school level in 2009-10 school year. The National Federation of States High Schools Association handbook 2010, 51-52. National Federation of State High Schools, Kansas City (MO).
2. DeHaas DM. NCAA sports sponsorship and participation rates report 1981-1982, 2007-2008. 2009. Available at: Accessed March 12, 2011. http://www.ncaapublications.com/productdownloads/PR2009.pdf.
3. Lopiano D. Gender equity in sports. Medical and orthopedic issues of active and athletic women 1994, 13-22. Hanley & Belfus, Philadelphia. R. Agostini (Ed.).
4. Yeager K.K., Agostini R., Nattiv A., et al. The female athlete triad: disordered eating, amenorrhea, osteoporosis. Med Sci Sports Exerc 1993, 25(7):775-777.
5. Otis C.L., Drinkwater B., Johnson M., et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 1997, 29(5):1669-1671.
6. Nattiv A., Loucks A.B., Manore M.M., et al. American College of Sports Medicine position stand. The female athlete triad. Med Sci Sports Exerc 2007, 39(10):1867-1882.
7. Beals K.A., Meyer N.L. Female athlete triad update. Clin Sports Med 2007, 26(1):69-89.
8. Loucks A.B. Low energy availability in the marathon and other endurance sports. Sports Med 2007, 37(4/5):348-352.
9. Practice Committee of the American Society for Reproductive Medicine Current evaluation of amenorrhea. Fertil Steril 2004, 82(1):266-272.
10. Leib E.S. Treatment of low bone mass in premenopausal women: when may it be appropriate?. Curr Osteoporos Rep 2005, 3(1):13-18.
11. Writing Group for the ISCD Position Development Conference Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom 2004, 7(1):17-26.
12. Leslie W.D., Adler R.A., El Hajj F.G., et al. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD official positions. J Clin Densitom 2006, 9(1):22-30.
13. Lebrun C.M. The female athlete triad: what's a doctor to do?. Curr Sports Med Rep 2007, 6:397-404.
14. Dook J.E., James C., Henderson N.K., et al. Exercise and bone mineral density in mature female athletes. Med Sci Sports Exerc 1997, 29(3):291-296.
15. To W.W., Wong M.W., Lam I.Y. Bone mineral density differences between adolescent dancers and non-exercising adolescent females. J Pediatr Adolesc Gynecol 2005, 18(5):337-342.
16. Cassell C., Benedict M., Specker B. Bone mineral density in elite 7- to 9-yr-old female gymnasts and swimmers. Med Sci Sports Exerc 1996, 28(10):1243-1246.
17. Nickols-Richardson S.M., Modlesky C.M., O'Connor P.J., et al. Premenarcheal gymnasts possess higher bone mineral density than controls. Med Sci Sports Exerc 2000, 32(1):63-69.
18. Hoch A.Z., Pajewski N.M., Moraski L., et al. Prevalence of the female athlete triad in high school athletes and sedentary students. Clin J Sport Med 2009, 19(5):421-428.
19. Nichols J.F., Rauh M.J., Lawson M.J., et al. Prevalence of the female athlete triad syndrome among high school athletes. Arch Pediatr Adolesc Med 2006, 160(2):137-142.
20. Beals K.A., Hill A.K. The prevalence of disordered eating, menstrual dysfunction, and low bone mineral density among US collegiate athletes. Int J Sport Nutr Exerc Metab 2006, 16(1):1-23.
21. Vardar S., Vardar E., Altun G., et al. Prevalence of the female athlete triad in Endirne, Turkey. J Sports Sci Med 2005, 4:550-555.
22. Cobb K.L., Bachrach L.K., Greendale G., et al. Disordered eating, menstrual irregularity, and bone mineral density in female runners. Med Sci Sports Exerc 2003, 35(5):711-719.
23. Hoch A.Z., Stavrakos J.E., Schimke J.E. Prevalence of female athlete triad characteristics in club triathlon team. Arch Phys Med Rehabil 2007, 88(5):681-682.
24. Torstveit M.K., Sundgot-Borgen J. The female athlete triad exists in both elite athletes and controls. Med Sci Sports Exerc 2005, 37(9):1449-1459.
25. Schtscherbyna A., Soares E., de Oliveira F., et al. Female athlete triad in elite swimmers of the city of Rio de Janeiro, Brazil. Nutrition 2009, 25(6):634-639.
26. Hoch A.Z., Papanek P., Szabo A., et al. Association between the female triad athlete and endothelial dysfunction in dancers. Clin J Sport Med 2011, 21(1):119-125.
27. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362(6423):801-809.
28. NCHS Health data interactive: centers for disease control and prevention. WISQARS leading causes of death reports, 1999-2006. AHA Heart Disease and Stroke Statistics 2010, Available at:, Accessed March 12, 2011. http://www.cdc.gov/nchs/fastats/deaths.htm.
29. Ross R. Atherosclerosis: current understanding of mechanisms and future strategies in therapy. Transplant Proc 1993, 25(2):2041-2043.
30. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340(2):115-126.
31. Thijssen D.H., Black M.A., Pyke K.E., et al. Assessment of flow mediated dilation (FMD) in humans: a methodological and technical guideline. Am J Physiol Heart Circ Physiol 2011, 300(1):H2-H12.
32. Celermajer D.S., Sorensen K.E., Gooch V.M., et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340(8828):1111-1115.
33. Walther C., Gielen S., Hambrecht R. The effect of exercise training on endothelial function in cardiovascular disease in humans. Exerc Sport Sci Rev 2004, 32(4):129-134.
34. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26(5):1235-1241.
35. Neunteufl T., Katzenschlager R., Hassan A., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997, 129(1):111-118.
36. Lieberman E.H., Gerhard M.D., Uehata A., et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol 1996, 78:1210-1214.
37. Schachinger V., Britten M.B., Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long- term outcome of coronary heart disease. Circulation 2000, 101(16):1899-1906.
38. Suwaidi J.A., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000, 101(9):948-954.
39. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002, 106(6):653-658.
40. Targonski P.V., Bonetti P.O., Pumper G.M., et al. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003, 107(22):2805-2809.
41. Hoch A.Z., Dempsey R.L., Carrera G.F., et al. Is there an association between athletic amenorrhea and endothelial cell dysfunction?. Med Sci Sports Exerc 2003, 35(3):377-383.
42. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., et al. Amenorrhea in female athletes is associated with endothelial dysfunction and unfavorable lipid profile. J Clin Endocrinol Metab 2005, 90(3):1354-1359.
43. Higashi Y., Sasaki S., Kurisu S., et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation 1999, 100(11):1194-1202.
44. DeSouza C.A., Shapiro L.F., Clevenger C.M., et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000, 102(12):1351-1357.
45. Donato A.J., Uberoi A., Bailey D.M., et al. Exercise-induced brachial artery vasodilation: effects of antioxidants and exercise training in elderly men. Am J Physiol Heart Circ Physiol 2010, 298(2):H671-H678.
46. Rickenlund A., Eriksson M.J., Schenck-Gustafsson K., et al. Oral contraceptives improve endothelial function in amenorrheic athletes. J Clin Endocrinol Metab 2005, 90(6):3162-3167.
47. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
48. Chlebowski R.T., Anderson G.L., Gass M., et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010, 304(15):1684-1692.
49. Wever R.M., van Dam T., van Rijn H.J., et al. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 1997, 237(2):340-344.
50. Verhaar M.C., Wever R.M., Kastelein J.J., et al. 5-Methyltetrahydrofolate, the active form of folic acid, restores endothelial function in familial hypercholesterolemia. Circulation 1998, 97(3):237-241.
51. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23(2):168-175.
52. Verhaar M.C., Wever R.M., Kastelein J.J., et al. Effects of oral folic acid supplementation on endothelial function in familial hypercholesterolemia: a randomized placebo-controlled trial [In Process Citation]. Circulation 1999, 100:335-338.
53. Maxwell A.J., Anderson B.E., Cooke J.P. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar. Vasc Med 2000, 5(1):11-19.
54. Wilmink H.W., Stroes E.S., Erkelens W.D., et al. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 2000, 20(1):185-188.
55. Title L.M., Cummings P.M., Giddens K., et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000, 36(3):758-765.
56. Title L.M., Ur E., Giddens K., et al. Folic acid improves endothelial dysfunction in type 2 diabetes-an effect independent of homocysteine-lowering. Vasc Med 2006, 11(2):101-109.
57. Moens A.L., Claeys M.J., Wuyts F.L., et al. Effect of folic acid on endothelial function following acute myocardial infarction. Am J Cardiol 2007, 99(4):476-481.
58. Woo K.S., Chook P., Chan L.L., et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med 2002, 112(7):535-539.
59. Hoch A.Z., Pajewski N.M., Hoffmann R.G., et al. Possible relationship of folic acid supplementation and improved flow-mediated dilation in premenopausal, eumenorrheic athletic women. Am J Sports Med 2009, 8:123-129.
60. Hoch A.Z., Lynch S.L., Jurva J.W., et al. Folic acid supplementation improves vascular function in amenorrheic runners. Clin J Sport Med 2010, 20(3):205-210.
61. Hoch A.Z., Papanek P., Havlik H.S., et al. Prevalence of the female athlete triad/tetrad in professional ballet dancers. Med Sci Sports Exerc 2009, 41(5):524.
62. Woo K.S., Chook P., Lolin Y.I., et al. Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. J Am Coll Cardiol 1999, 34(7):2002-2006.
63. US Food and Drug Administration The FDA safety information and adverse event reporting program: medical product safety information Available at:, Accessed November 20, 2010. http://www.fda.gov/medwatch/SAFETY.htm.
64. Herbert V. Folic acid. Modern nutrition in health and disease 1999, 433-466. Williams & Wilkins, Baltimore (MD). M. Shils, J. Olson, M. Shike (Eds.).
65. National Institutes of Health National Institutes of Health, Office of Dietary Supplements. Dietary supplement fact sheet: folate Available at:, Accessed November 19, 2010. http://ods.od.nih.gov/factsheets/folate.asp%23en10.
66. Cole B.F., Baron J.A., Sandler R.S., et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007, 297(21):2351-2359.
67. Biro G., Hulshof K.F., Ovesen L., et al. Selection of methodology to assess food intake. Eur J Clin Nutr 2002, 56(Suppl 2):S25-S32.
68. Williams N.I., Helmreich D.L., Parfitt D.B., et al. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab 2001, 86(11):5184-5193.
69. Williams N.I. Lessons from experimental disruptions of the menstrual cycle in humans and monkeys. Med Sci Sports Exerc 2003, 35(9):1564-1572.
70. Golden N.H., Jacobson M.S., Schebendach J., et al. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997, 151(1):16-21.
71. Fredericson M., Kent K. Normalization of bone density in a previously amenorrheic runner with osteoporosis. Med Sci Sports Exerc 2005, 37(9):1481-1486.
72. Winters-Stone K.M., Snow C.M. Musculoskeletal response to exercise is greatest in women with low initial values. Med Sci Sports Exerc 2003, 36(4):1691-1696.
73. McNicholl D.M., Heaney L.G. The safety of bisphosphonate use in pre-menopausal women on corticosteroids. Curr Drug Saf 2010, 5(2):182-187.
74. Hausenblas H.A., Carron A.V. Eating disorder indices and athletes: an integration. J Sport Exerc Psychol 1999, 21:230-258.
75. Striegel-Moore R.H., Silberstein L.R., Rodin J. Toward an understanding of risk factors for bulimia. Am Psychol 1986, 41(3):246-263.
76. Sundgot-Borgen J., Corbin C. Eating disorders among female athletes. Phys Sportsmed 1987, 15(2):89-95.
77. Sundgot-Borgen J., Torstveit M.K. Prevalence of eating disorders in elite athletes is higher than in the general population. Clin J Sport Med 2004, 14(1):25-32.
78. Dick R.W. Eating disorders in NCAA athletic programs. J Athl Train 1991, 26:136-140.
79. Johnson J.G., Cohen P., Kasen S., et al. Eating disorders during adolescence and the risk for physical and mental disorders during early adulthood. Arch Gen Psychiatry 2002, 59(6):545-552.
80. Patton G.C., Selzer R., Coffey C., et al. Onset of adolescent eating disorders: population based cohort study over 3 years. BMJ 1999, 318(7186):765-768.
81. Lewinsohn P.M., Striegel-Moore R.H., Seeley J.R. Epidemiology and natural course of eating disorders in young women from adolescence to young adulthood. J Am Acad Child Adolesc Psychiatry 2000, 39(10):1284-1292.
82. Hoek H.W., van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord 2003, 34(4):383-396.
83. Crow S.J., Peterson C.B., Swanson S.A., et al. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry 2009, 166(12):1342-1346.
84. Thompson R.A. Management of the athlete with an eating disorder: implications for the sport management team. Sport Psychol 1987, 1:114-126.
85. Thompson R.A., Sherman R. Eating disorders in sport 2010, Routledge/Taylor & Francis Group, New York.
86. Bonci C.M., Bonci L.J., Granger L.R., et al. National Athletic Trainers' Association position statement: preventing, detecting, and managing disordered eating in athletes. J Athl Train 2008, 43:80-108.
87. Trattner-Sherman R., Thompson R.A. Athletes and disordered eating: four major issues for the professional psychologist. Prof Psychol Res Pr 2001, 32(1):27-33.
88. Managing student-athletes' mental health issues 2007, National Collegiate Athletic Association, Indianapolis (IN).
89. Hildebrandt T. A review of eating disorders in athletes: recommendations for secondary school prevention and intervention programs. J Appl Sch Psychol 2005, 21(2):145-167.
90. Forman E., Herbert J. New directions in cognitive behavior therapy: acceptance-based therapies. General principles and empirically supported techniques of cognitive behavior therapy 2009, 77-101. John Wiley & Sons, Inc, Hoboken (NJ). W. O'Donohue, J. Fisher (Eds.).
91. Fairburn C.G., Marcus M., Wilson G. Cognitive-behavioral therapy for binge eating and bulimia nervosa: a comprehensive treatment manual. Binge eating: Nature, assessment, and treatment 1993, 361-404. Guilford Press, New York. C.G. Fairburn, G. Wilson (Eds.).
92. Juarascio A.S., Forman E.M., Herbert J.D., et al. Acceptance and commitment therapy versus cognitive therapy for the treatment of comorbid eating pathology. Behav Modif 2010, 34(2):175-190.
93. Brownley K.A., Berkman N.D., Sedway J.A., et al. Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007, 40(4):337-348.
94. Shapiro J.R., Berkman N.D., Brownley K.A., et al. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord 2007, 40(4):321-336.
95. Wilson G.T., Grilo C.M., Vitousek K.M. Classification of eating disorders: toward DSM-V. Int J Eat Disord 2007, 40:S123-S129.
96. Mitchell J.E., Agras S., Wonderlich S. Treatment of bulimia nervosa: where are we and where are we going?. Int J Eat Disord 2007, 40(2):95-101.
97. Vanderlinden J. Many roads lead to Rome: why does cognitive behavioural therapy remain unsuccessful for many eating disorder patients?. Eur Eat Disord Rev 2008, 16(5):329-333.
98. Guarda A.S. Treatment of anorexia nervosa: insights and obstacles. Physiol Behav 2008, 94(1):113-120.
99. Hayes S.C., Wilson K.G. Acceptance and commitment therapy: altering the verbal support for experiential avoidance. Behav Anal 1994, 17(2):289-303.
100. Hayes S.C., Strosahl K.D., Wilson K.G. Acceptance and commitment therapy: an experiential approach to behavior change 2003, Guilford, New York.
101. Hayes S.C. Acceptance and commitment therapy, relational frame theory, and the third wave of behavior therapy. Behav Ther 2004, 35:639-665.
102. Heffner M., Sperry J., Eifert G.H., et al. Acceptance and commitment therapy in the treatment of an adolescent female with anorexia nervosa: a case example. Cognit Behav Pract 2002, 9(3):232-236.
103. Baer R., Fischer S., Huss D. Mindfulness and acceptance in the treatment of disordered eating. J Ration Emot Cogn Behav Ther 2005, 23(4):281-300.
104. Kristeller J.L., Baer R., Quillian-Wolever R. Mindfulness-based approaches to eating disorders. Mindfulness-based treatment approaches 2006, 75-91. Elsevier, San Diego (CA). R. Baer (Ed.).
105. Linehan M.M. Skills training manual for treating borderline personality disorder 1993, Guilford Press, New York.
106. Chen E.Y., Matthews L., Allen C., et al. Dialectical behavior therapy for clients with binge-eating disorder or bulimia nervosa and borderline personality disorder. Int J Eat Disord 2008, 41(6):505-512.
107. Ben Porath D.D., Wisniewski L., Warren M. Differential treatment response for eating disordered patients with and without a comorbid borderline personality diagnosis using a dialectical behavior therapy (DBT)-informed approach. Eat Disord 2009, 17(3):225-241.
108. Heatherton T.F., Baumeister R.F. Binge eating as escape from self-awareness. Psychol Bull 1991, 110(1):86-108.
109. Safer D.L., Telch C.F., Agras W.S. Dialectical behavior therapy for bulimia nervosa. Am J Psychiatry 2001, 158(4):632-634.
110. Fairburn C.G. Cognitive behavior therapy and eating disorders 2008, The Guilford Press, New York.
111. Bissada H. Review of 'Cognitive behavior therapy and eating disorders'. Can J Psychiatry 2009, 54(11):783-784.
112. Fairburn C.G., Cooper Z., Doll H.A., et al. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders: a two-site trial with 60-week follow-up. Am J Psychiatry 2009, 166(3):311-319.
113. Carter W.P., Hudson J.I., Lalonde J.K., et al. Pharmacologic treatment of binge eating disorder. Int J Eat Disord 2003, 34(S1):S74-S88.
114. Stefano S.C., Bacaltchuk J., Blay S.L., et al. Antidepressants in short-term treatment of binge eating disorder: systematic review and meta-analysis. Eat Behav 2008, 9(2):129-136.
115. Guerdjikova A.I., McElroy S.L., Kotwal R., et al. High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial. Hum Psychopharmacol Clin Exp 2008, 23(1):1-11.
116. McElroy S.L., Hudson J.I., Capece J.A., et al. Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study. Biol Psychiatry 2007, 61(9):1039-1048.
117. McElroy S.L., Kotwal R., Guerdjikova A.I., et al. Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry 2006, 68(1):1897-1906.
118. McElroy S.L., Guerdjikova A., Kotwal R., et al. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial. J Clin Psychiatry 2007, 68(3):390-398.
119. Powers P.S., Santana C.A., Bannon Y.S. Olanzapine in the treatment of anorexia nervosa: an open label trial. Int J Eat Disord 2002, 32(2):146-154.
120. Appolinario J.C., Bacaltchuk J., Sichieri R., et al. A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 2003, 60(11):1109-1116.
121. Grilo C.M., Masheb R.M., Salant S.L. Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial. Biol Psychiatry 2005, 57(10):1193-1201.
122. Wilfley D.E., Crow S.J., Hudson J.I., et al. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry 2008, 165(1):51-58.
123. Bellini M., Merli M. Current drug treatment of patients with bulimia nervosa and binge-eating disorder: selective serotonin reuptake inhibitors versus mood stabilizers. Int J Psychiatr Clin Pract 2004, 8(4):235-243.
124. Crow S.J., Mitchell J.E., Roerig J.D., et al. What potential role is there for medication treatment in anorexia nervosa?. Int J Eat Disord 2009, 42(1):1-8.
125. Pike K.M., Hilbert A., Wilfley D.E., et al. Toward an understanding of risk factors for anorexia nervosa: a case-control study. Psychol Med 2008, 38(10):1443-1453.
126. Zhu A.J., Walsh B.T. Pharmacologic treatment of eating disorders. Can J Psychiatry 2002, 47(3):227-234.
127. Baum A. Eating disorders in the male athlete. Sports Med 2006, 36(1):1-6.
128. National Collegiate Athletic Association 2010-11 NCAA banned drugs. PrFont34Bin0BinSub0Frac0Def1Margin0Margin0Jc1Indent1440Lim0Lim1 Available at:, Accessed November 23, 2010. http://www.ncaa.org/wps/portal/ncaahome?WCM_GLOBAL_CONTEXT=/ncaa/ncaa/legislation+and+governance/eligibility+and+recruiting/drug+testing/ncaa+banned-drug+classes.
129. Carter J.C., Stewart D.A., Dunn V.J., et al. Primary prevention of eating disorders: might it do more harm than good?. Int J Eat Disord 1997, 22(2):167-172.
130. Moreno A.B., Thelen M.H. A preliminary prevention program for eating disorders in a junior high school population. J Youth Adolesc 1993, 22(2):109-124.
131. Stice E., Shaw H. Eating disorder prevention programs: a meta-analytic review. Psychol Bull 2004, 130(2):1-23.
132. Neumark-Sztainer D., Butler R., Palti H. Eating disturbances among adolescent girls: evaluation of a school-based primary prevention program. J Nutr Educ 1995, 27(1):24-31.
133. Stice E., Mazotti L., Weibel D., et al. Dissonance prevention program decreases thin-ideal internalization, body dissatisfaction, dieting, negative affect, and bulimic symptoms: a preliminary experiment. Int J Eat Disord 2000, 27(2):206-217.
134. Stoolmiller M., Eddy J.M., Reid J.B. Detecting and describing preventive intervention effects in a universal school-based randomized trial targeting delinquent and violent behavior. J Consult Clin Psychol 2000, 68(2):296-306.
135. Elliot D.L., Moe E.L., Goldberg L., et al. Definition and outcome of a curriculum to prevent disordered eating and body-shaping drug use. J Sch Health 2006, 76(2):67-73.
136. Elliot D.L., Goldberg L., Moe E.L., et al. Long-term outcomes of the ATHENA (Athletes Targeting Healthy Exercise & Nutrition Alternatives) program for female high school athletes. J Alcohol Drug Educ 2008, 52(2):73-92.
137. Stice E., Shaw H., Becker C., et al. Dissonance-based interventions for the prevention of eating disorders: using persuasion principles to promote health. Prev Sci 2008, 9(2):114-128.
138. Stice E., Trost A., Chase A. Healthy weight control and dissonance-based eating disorder prevention programs: results from a controlled trial. Int J Eat Disord 2003, 33(1):10-21.
139. Becker C.B., Wilson C., Williams A., et al. Peer-facilitated cognitive dissonance versus healthy weight eating disorders prevention: a randomized comparison. Body Image 2010, 7(4):280-288.
140. Larimer M.E., Cronce J.M. Identification, prevention and treatment: a review of individual-focused strategies to reduce problematic alcohol consumption by college students. J Stud Alcohol 2002, 14:148-163.
141. Beck A.T. Cognitive therapy: nature and relation to behavior therapy. Behav Ther 1970, 1(2):184-200.
142. Telch C.F., Agras W.S., Linehan M.M. Dialectical behavior therapy for binge eating disorder. J Consult Clin Psychol 2001, 69(6):1061-1065.
143. Ben-Porath D.D., Wisniewski L., Warren M. Differential treatment response for eating disordered patients with and without a comorbid borderline personality diagnosis using a dialectical behavior therapy (DBT)-informed approach. Eat Disord 2009, 17(3):225-241.
144. Matusek J.A., Wendt S.J., Wiseman C.V. Dissonance thin-ideal and didactic healthy behavior eating disorder prevention programs: results from a controlled trial. Int J Eat Disord 2004, 36(4):376-388.
145. Green M., Scott N., Diyankova I., et al. Eating disorder prevention: an experimental comparison of high level dissonance, low level dissonance, and no-treatment control. Eat Disord 2005, 13(2):157-169.
146. Black Becker C., Bull S., Smith L.M., et al. Effects of being a peer-leader in an eating disorder prevention program: can we further reduce eating disorder risk factors?. Eat Disord 2008, 16(5):444-459.